NCT07782229 Appetite and Cognition Response to a Breakfast Cereal
| NCT ID | NCT07782229 |
| Status | Recruiting |
| Phase | — |
| Sponsor | General Mills |
| Condition | Cognition |
| Study Type | INTERVENTIONAL |
| Enrollment | 184 participants |
| Start Date | 2026-09-14 |
| Primary Completion | 2026-09-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 184 participants in total. It began in 2026-09-14 with a primary completion date of 2026-09-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to examine appetite and cognition responses following consumption of a ready-to-eat breakfast cereal.
Eligibility Criteria
Inclusion Criteria: * Healthy adults 18-70 years * Habitual breakfast cereal consumers (at least several times per month) * Body mass index 18.5-29.9 kg/m2 (based on self-reported weight and height) * Understand and willing to follow the study procedures, including having access to a tablet or laptop to use the online platforms for appetite and cognition measurement * Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial * Willing to abstain from strenuous exercise, consuming alcoholic drinks 24 hours before the test day * Willing to provide informed consent to participate in the study Exclusion Criteria: * Age or body mass index outside of the inclusion criteria * Pregnant or lactating women, or women who are planning to become pregnant during the study * Known food allergies, sensitivities, or intolerance to any food or food ingredients * Participating in another clinical trial for food, investigational drug, nutritional supplement, or lifestyle modification * Taking medications that affect appetite, metabolism or blood pressure * Presence of acute diseases or infection * Presence or history of chronic diseases * Diagnosed with an eating disorder * Restraint eaters as determined by a score \>4 from the Dutch Eating Behavior Questionnaire1 * Lost or gained 5 or more pounds in the past 3-months * On a weight loss diet or undergoing intermittent fasting * COVID-19 infection within the past 3 months * Subjects who do not eat cereal products * Subjects who do not understand or are not willing to follow the study procedures
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07782229 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Cognition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07782229 currently recruiting?
Yes, NCT07782229 is actively recruiting participants. Contact the research team at taylor.banh@genmills.com for enrollment information.
Where is the NCT07782229 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT07782229 clinical trial?
NCT07782229 is sponsored by General Mills. The trial plans to enroll 184 participants.